FOXO4-DRI

experimental
FOXO4-D-Retro-InversoSenolytic peptideProxofim

A senolytic peptide that selectively induces apoptosis in senescent cells by disrupting the FOXO4-p53 interaction.

Category
anti aging
Dosage
5-10 mg/kg in animal studies (no established human dose)
Half-Life
Extended due to D-amino acid structure (estimated days)
Administration
Intravenous infusion (animal studies)

Overview

FOXO4-DRI is a D-retro-inverso peptide designed to interfere with the FOXO4-p53 protein interaction that keeps senescent ("zombie") cells alive. Developed by Dr. Peter de Keizer at Erasmus University Medical Center in the Netherlands, it was published in Cell in 2017.

Senescent cells accumulate with age and secrete inflammatory factors (SASP) that damage surrounding tissue and accelerate aging. FOXO4-DRI works by competitively binding to p53, preventing FOXO4 from sequestering it in the nucleus, thereby triggering selective apoptosis of senescent cells while leaving healthy cells unaffected. In aged mice, it restored fitness, fur density, and kidney function.

SUPPLIER OPTIONS

Review FOXO4-DRI options

Review FOXO4-DRI product information and ordering options from Ascension Peptides.

✓ Review supplier documentation✓ Check product details✓ Check shipping terms
View FOXO4-DRI
from Ascension Peptides
Research-use informationReview supplier policies

Affiliate link: DailyVial may earn a commission from qualifying purchases. Learn more.

Benefits

  • Selectively eliminates senescent cells
  • Reduces inflammatory SASP factors
  • Restored physical fitness in aged mice
  • Improved kidney function in animal models
  • Targets aging at a fundamental cellular level
  • Spares healthy non-senescent cells

Side Effects

  • No human clinical data available
  • Theoretical risk of excessive cell death
  • Potential immune system effects
  • Very expensive to synthesize
  • Unknown long-term consequences of senescent cell clearance
  • Experimental — no established safety profile

Where to Source FOXO4-DRI

Quality and purity matter with peptides. Only buy from suppliers that provide third-party Certificate of Analysis (COA) testing. Compare verified sources below:

Ascension Peptides

Third-party tested, US-based peptide supplier with COAs on every batch.

Review current supplier documentation before purchasing.

Listed product: FOXO4-DRI
Supplier details may change; review the linked listing.

Quick Comparison Guide

Quality
COA + 3rd party testing required
Purity
≥95% minimum standard
Storage
Lyophilized powder preferred
Shipping
Cold chain when needed

🔍 Buying Tips for FOXO4-DRI

  • • Always request Certificate of Analysis (COA) before purchasing
  • • Verify the supplier's testing methodology and third-party lab credentials
  • • Look for proper cold storage and shipping practices
  • • Start with smaller quantities to test supplier quality
  • • Join peptide communities for supplier reviews and experiences

Disclosure: DailyVial may earn a commission from qualifying purchases. This doesn't affect our editorial recommendations. See our affiliate disclosure for details.

⚠ Research Disclaimer: This information is for educational purposes only and is not medical advice. Consult a qualified healthcare professional before using FOXO4-DRI or any peptide. See our full medical disclaimer.

Explore More Anti-Aging Peptides

Longevity peptides targeting cellular aging, mitochondria, and gene expression

View All Anti-Aging Peptides

Related Peptides

DailyVial can use Google Analytics to understand site usage. Analytics is off unless you choose to allow it. See our Privacy Policy.